Ukrain

Title Average Ratingsort ascending
Why is not Ukrain approved yet in Austria/EU? 98.57%
Ukrain (NSC-631570) in the treatment of pancreas cancer. 95.00%
Ukrain - a new cancer cure? A systematic review of randomised clinical trials. 90.00%
Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice 90.00%
Clinical Investigations on Ukrain 90.00%
Pre-Clinical Investigations on Ukrain 90.00%
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors 90.00%
WHO’S AFRAID OF A CURE FOR CANCER? - The struggle for an alternative cancer drug 90.00%
Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. 90.00%
Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure 90.00%
In-vitro toxicity of Ukrain against human Ewing tumor cell lines. 90.00%
Debate in Lancet about setting up a phase II trial on Ukrain in England 90.00%
71 year old woman, Pancraetic cancer with liver and lung metastasis. 90.00%
NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial 85.00%
Ukrain: Debated Subjects 80.00%
A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation 80.00%
Antinociceptive effect of ten day administration of Ukrain in mice and interaction of the treatment with morphine 80.00%
Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. 80.00%
Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour ce 80.00%
Ukrain Debate 1: What is the active Substance of Ukrain? 80.00%
Interaction between Ukrain and Naltrexone in the writhing syndrome test in mice 80.00%
The influence of glucose, succinate, pH of the medium and higher temperature on the cytotoxic activity of the preparation Ukrain 80.00%
Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer 80.00%
The dynamics of concentration of the main fluorescent component of Ukrain in the tissues and blood plasma of rats with W-256 ... 80.00%
Comparative evaluation of the complex treatment of rectal cancer patients (chemotherapy and X-ray therapy, Ukrain monotherapy) 80.00%
National Cancer Institute, National Institute of Health: Developmental Therapeutics Program. NSC 631570: results of the Human Ce 80.00%
Effect of Ukrain on matrix metalloproteinase-2 and Secreted Protein Acidic and Rich in Cysteine (SPARC) expression in human.... 80.00%
Inhibition of liver mitochondrial monoamine oxidase activity by alkaloids isolated from Chelidonium and Macleaya and by their de 80.00%
The antimitotic effects of Ukrain, a Chelidonium majus alkaloid derivative, are reversible in vitro. 80.00%
Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma 80.00%
Ukrain therapy of recurrent breast cancer with lung metastases (case report) 80.00%
Clinical studies of Ukrain in terminal cancer patients (phase II) 80.00%
Induced G2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrain 80.00%
Ukrain monotherapy in malignant melanoma (case report) 80.00%
Ukrain acts by inhibition of tubulin polymerization in normal and malignant cell lines. 80.00%
Effect of some isoquinoline alkaloids on enzymatic activity of acetylcholinesterase and monoamine oxidase 80.00%
Induction of apoptosis in cultured Chinese hamster ovary cells by Ukrain and its synergistic action with etoposide. 80.00%
The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer. 75.00%
Preliminary results of individual therapy of chronic hepatitis C by Ukrain and interferon-alpha. 70.00%
NF-kappaB does not influence the induction of apoptosis by Ukrain. 70.00%
Ukrain treatment in a patient with breast carcinoma 70.00%
The effects of chelidonine on tubulin polymerisation, cell cycle progression and selected signal transmission pathways 70.00%
Efficacy of ukrain in the treatment of pancreatic cancer. 70.00%
Selective inhibition of in vitro cell growth by the anti-tumour drug Ukrain 70.00%
Ukrain treatment in carcinoma of the oesophagus (case report) 70.00%
Animal studies on Ukrain 65.00%
Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. 65.00%
Chelidonium majus L. (Ukrain) in the treatment of cancer patients. 63.33%
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas. 63.33%
Ukrain 62.22%
New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder 60.00%
Combined therapy with Ukrain and chemotherapy in ovarian cancer (case report) 60.00%
Does the Ukrain preparation protect mice against lethal doses of bacteria? 60.00%
The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky 60.00%
Cysteine proteinases and their inhibitors in the development of mouse HA-1 hepatoma and antineoplastic therapy 60.00%
Ukrain therapy of stage T1N0M0 bladder cancer patients 60.00%
Ukrain treatment in carcinoma of the cervix (case report) 60.00%
Theoretical grounds and experimental confirmation of the antiviral effect of the 60.00%
Biophysiological effects of Ukrain therapy in a patient with breast cancer (case report) 60.00%
Clinical studies of Ukrain in healthy volunteers (phase 1). 60.00%
Radiomodification effects of Ukrain, a cytostatic and immunomodulating drug, on intracellular glucocorticoid reception during sh 60.00%
Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumour and normal cells 60.00%
Ukrain both as an anti cancer and immunoregulatory agent 60.00%
Bcl-2 overexpression protects human keratinocyte cells from Ukrain-induced apoptosis but not from G2/M arrest. 60.00%
The influence of the novel drug Ukrain on hemo- and immunopoiesis at the time of its maximum radioprotective effect 60.00%
Preliminary studies on the effect of Ukrain on the immunological response in patients with malignant tumours. 60.00%
Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid 55.00%
Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report) 50.00%
Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. 50.00%
Results of Ukrain monotherapy of prostate cancer 50.00%
Effect of alkaloid sanguinarine and a pharmaceutical preparation ukrain on modulation of vesicular membrane fusion and actin.... 50.00%
Ukrain (NSC-631570) influences on bone status: a review. 50.00%
A method for determination of Ukrain in blood plasma for monitoring and pharmacokinetic study 50.00%
Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured gliobl 50.00%
Influence of Ukrain on the nuclear thyroid hormone receptors after short-term gamma-irradiation. 50.00%
Six-week treatment with Ukrain in rabbits. Part I: Morphological parameters 50.00%
Some pharmacological properties of prolonged administration of Ukrain in rodents 50.00%
Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies.... 50.00%
A study of the influence of a novel drug Ukrain on in vivo effects of low-dose ionizing radiation 50.00%
Morphometric and kinetic analysis of the growth of experimental sarcoma-45 in the presence of Ukrain 50.00%
Ukrain in the treatment of urethral recurrent carcinoma (case report) 50.00%
Ukrain with chemotherapy in malignant melanoma (case report) 50.00%
Comparative in vitro study of the effects of the new antitumor drug Ukrain and several cytostatic agents on the thiol groups in 50.00%
Biological activity of some thiophosphamide derivatives of alkaloids with respect to influenza virus 50.00%
Modification of antinociceptive action of morphine by Ukrain in rodents 50.00%
Ukrain: acute toxicity after intravenous, intramuscular and oral administration in rats 40.00%
Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report) 40.00%
Enhancement of macrophage tumouricidal activity by the alkaloid derivative 40.00%
Ukrain treatment of a patient with retroperitoneal synovial sarcoma. 35.00%
The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy 30.00%
Effect of Ukrain on the efficacy of anti-epileptic drugs against maximal electroshock-induced seizures in mice. 30.00%
Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. 30.00%
The immunomodulating preparation Ukrain does not induce anaphylactic sensitization in mice and guinea pigs 20.00%
Six-week treatment with Ukrain in rabbits. Part II: Serum levels of gonadal hormones 20.00%
Ukrain therapy of a recurrent astrocytoma of the optic nerve (case report) 20.00%
Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain. 20.00%
Teratological evaluation of Ukrain in hamsters and rats 0.00%
Evaluation of mutagenic, genotoxic and transforming properties of Ukrain 0.00%
Effect of Ukrain on human liver alcohol dehydrogenase activity in vitro. 0.00%
Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain. 0.00%

Pages